BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 20678718)

  • 1. Cognitive effects of topiramate revealed by standardised low-resolution brain electromagnetic tomography (sLORETA) of event-related potentials.
    Jung KY; Cho JW; Joo EY; Kim SH; Choi KM; Chin J; Park KW; Hong SB
    Clin Neurophysiol; 2010 Sep; 121(9):1494-1501. PubMed ID: 20678718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of adjunctive topiramate on cognitive function in patients with epilepsy.
    Lee S; Sziklas V; Andermann F; Farnham S; Risse G; Gustafson M; Gates J; Penovich P; Al-Asmi A; Dubeau F; Jones-Gotman M
    Epilepsia; 2003 Mar; 44(3):339-47. PubMed ID: 12614389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes of the event related potential P300 following topiramate treatment in children with epilepsy].
    Yang W; Li M
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Oct; 10(5):583-5. PubMed ID: 18947474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The longer-term cognitive effects of adjunctive antiepileptic treatment with lacosamide in comparison with lamotrigine and topiramate in a naturalistic outpatient setting.
    Helmstaedter C; Witt JA
    Epilepsy Behav; 2013 Feb; 26(2):182-7. PubMed ID: 23318473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential cognitive and behavioral effects of topiramate and valproate.
    Meador KJ; Loring DW; Hulihan JF; Kamin M; Karim R;
    Neurology; 2003 May; 60(9):1483-8. PubMed ID: 12743236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attention changes in epilepsy patients following 3-month topiramate or valproate treatment revealed by event-related potential.
    Sun W; Wang Y; Wang W; Wu X
    Int J Psychophysiol; 2008 Jun; 68(3):235-41. PubMed ID: 18378030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered cerebral activity associated with topiramate and its withdrawal in patients with epilepsy with language impairment: An fMRI study using the verb generation task.
    Tang Y; Xia W; Yu X; Zhou B; Wu X; Lui S; Luo C; Huang X; Ouyang L; Chen Q; Gong Q; Zhou D
    Epilepsy Behav; 2016 Jun; 59():98-104. PubMed ID: 27123530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of topiramate on cognitive fMRI.
    Yasuda CL; Centeno M; Vollmar C; Stretton J; Symms M; Cendes F; Mehta MA; Thompson P; Duncan JS; Koepp MJ
    Epilepsy Res; 2013 Jul; 105(1-2):250-5. PubMed ID: 23333471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significant improvement in frontal lobe associated neuropsychological functions after withdrawal of topiramate in epilepsy patients.
    Kockelmann E; Elger CE; Helmstaedter C
    Epilepsy Res; 2003 May; 54(2-3):171-8. PubMed ID: 12837568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive profile of topiramate as compared with lamotrigine in epilepsy patients on antiepileptic drug polytherapy: relationships to blood serum levels and comedication.
    Kockelmann E; Elger CE; Helmstaedter C
    Epilepsy Behav; 2004 Oct; 5(5):716-21. PubMed ID: 15380124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive effects of low-dose topiramate monotherapy in epilepsy patients: A 1-year follow-up.
    Lee HW; Jung DK; Suh CK; Kwon SH; Park SP
    Epilepsy Behav; 2006 Jun; 8(4):736-41. PubMed ID: 16647301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive and behavioral effects of lamotrigine and topiramate in healthy volunteers.
    Meador KJ; Loring DW; Vahle VJ; Ray PG; Werz MA; Fessler AJ; Ogrocki P; Schoenberg MR; Miller JM; Kustra RP
    Neurology; 2005 Jun; 64(12):2108-14. PubMed ID: 15985582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain's compensatory response to drug-induced cognitive impairment.
    Babu Henry Samuel I; Barkley C; Marino SE; Wang C; Han SM; Birnbaum AK; Cibula JE; Ding M
    J Clin Exp Neuropsychol; 2018 Dec; 40(10):1000-1012. PubMed ID: 29720037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional MRI reveals declined prefrontal cortex activation in patients with epilepsy on topiramate therapy.
    Jansen JF; Aldenkamp AP; Marian Majoie HJ; Reijs RP; de Krom MC; Hofman PA; Eline Kooi M; Nicolay K; Backes WH
    Epilepsy Behav; 2006 Aug; 9(1):181-5. PubMed ID: 16793345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of antiepileptic drugs on cognition: a comparison of levetiracetam with topiramate.
    Gomer B; Wagner K; Frings L; Saar J; Carius A; Härle M; Steinhoff BJ; Schulze-Bonhage A
    Epilepsy Behav; 2007 May; 10(3):486-94. PubMed ID: 17409025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of topiramate on neurophysiological and neuropsychological tests in migraine patients.
    Kececi H; Atakay S
    J Clin Neurosci; 2009 Dec; 16(12):1588-91. PubMed ID: 19793661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired verbal fluency under topiramate--evidence for synergistic negative effects of epilepsy, topiramate, and polytherapy.
    Witt JA; Elger CE; Helmstaedter C
    Eur J Neurol; 2013 Jan; 20(1):130-7. PubMed ID: 22827489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of topiramate and gabapentin on cognitive abilities in healthy volunteers.
    Salinsky MC; Storzbach D; Spencer DC; Oken BS; Landry T; Dodrill CB
    Neurology; 2005 Mar; 64(5):792-8. PubMed ID: 15753411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of topiramate and zonisamide on fMRI cognitive networks.
    Wandschneider B; Burdett J; Townsend L; Hill A; Thompson PJ; Duncan JS; Koepp MJ
    Neurology; 2017 Mar; 88(12):1165-1171. PubMed ID: 28213372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive effects of lamotrigine compared with topiramate in patients with epilepsy.
    Blum D; Meador K; Biton V; Fakhoury T; Shneker B; Chung S; Mills K; Hammer A; Isojärvi J
    Neurology; 2006 Aug; 67(3):400-6. PubMed ID: 16894098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.